| Name | Title | Contact Details |
|---|
Eskaton is a nonprofit senior services provider serving Northern California`s older adults for over 50 years. Through innovative approaches to health, housing and social services, Eskaton is Transforming the Aging Experience by offering life-enriching experiences and creating a culture of purposeful living. Well-being is the very center of our philosophy, and we express our belief that Age is Beautiful by celebrating the lives of older adults throughout the Eskaton family. Certified in 2019 as “A Great Place to Work” by Fortune Magazine, Eskaton genuinely cares about the financial security, health and well-being of their staff members. In addition to competitive pay and comprehensive benefits that include a company-funded retirement program, Eskaton employees appreciate knowing their work makes a real difference—both in the community, and in the lives they touch. (129/744) Employment opportunities at Eskaton our wide-ranging, including (but not limited to) the following: • Administration • Nursing • Care-Giving • Maintenance • Dining Services • Housekeeping • Security
Rotem is a Durham, NC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Ohio County EMS is a Hartford, KY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Salus Surgical Group is a Beverly Hills, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Portola Pharmaceuticals is dedicated to developing and commercializing therapies that transform patient lives and advance patient care by changing treatment paradigms in thrombosis and other hematologic diseases. Our two lead assets are Bevyxxa® (betrixaban), and andexanet alfa. In addition, cerdulatinib is our investigational Syk/JAK inhibitor to treat hematologic cancers. These compounds come from our own internal research efforts and represent important advances to address significant unmet needs. We are employing novel strategies that may increase the likelihood of clinical, regulatory and commercial success of our potentially lifesaving therapies.